The influenza virus hemagglutinin (HA) facilitates viral entry into target cells. Cleavage of HA by host cell proteases is essential for viral infectivity and the responsible enzymes are potential targets for antiviral intervention. The type II transmembrane serine protease (TTSP) TMPRSS2 has been identified as an HA activator in cell culture and in the infected host. However, it is less clear whether TMPRSS2-related enzymes can also activate HA for spread in target cells. Moreover, the activity of cellular serine protease inhibitors against HA-activating TTSPs is poorly understood. Here, we show that TMPRSS11A, another member of the TTSP family, cleaves and activates the influenza A virus (FLUAV) HA and the Middle East respiratory syndrome coronavirus spike protein (MERS-S). Moreover, we demonstrate that TMPRSS11A is expressed in murine tracheal epithelium, which is a target of FLUAV infection, and in human trachea, suggesting that the protease could support FLUAV spread in patients. Finally, we show that HA activation by the TMPRSS11A-related enzymes HAT and DESC1 but not TMPRSS11A itself is blocked by the cellular serine protease Influenza viruses, members of the family Orthomyxoviridae, are enveloped viruses with a negative sense, segmented RNA genome. Influenza viruses readily adapt to immune pressure and thus constantly circulate in the human population, causing annual influenza epidemics (1,2). Moreover, reassortment of genomic segments between different influenza A viruses can result in the emergence of antigenically new viruses, which may spread pandemically (1,2). The constantly changing nature of influenza viruses also compromises the efficacy of currently available antivirals, since the viruses can rapidly acquire resistance-conferring mutations (3). This may not be the case if host cell factors were targeted, which are required for viral spread but dispensable for cellular survival, and the identification of such factors is in the focus of current research efforts (4).The viral hemagglutinin protein (HA) is incorporated into the viral envelope and facilitates influenza virus entry into target cells (5,6). For this, the surface unit of HA, termed HA1, binds to sialic acids on cell surface receptors and stimulates viral uptake into host cell endosomes. Thereafter, the transmembrane unit HA2 fuses the viral and the endosomal membrane, allowing the delivery of the viral genomic information into the cellular cytoplasm (5,6). HA is synthesized as an inactive precursor protein, HA0, and cleavage of HA0 by host cell proteases primes HA for membrane fusion, which is triggered by endosomal low pH (7,8). The priming of HA, which, for historic reasons, will subsequently be referred to as HA activation, is essential for viral infectivity.As a consequence, the host cell proteases responsible for HA activation are potential targets for antiviral intervention.Evidence is constantly accumulating that the type II transmembrane serine protease TMPRSS2 plays an important role in HA activation. Thus, TMPRSS2 activates H...